Tech Company Financing Transactions
Ra Pharmaceuticals Funding Round
Morgenthaler Ventures and private investors participated in a $10.3 million venture round for Ra Pharmaceuticals. The round closed on 2/25/2010.
Transaction Overview
Company Name
Announced On
2/25/2010
Transaction Type
Venture Equity
Amount
$10,300,000
Round
Undisclosed
Investors
Morgenthaler Ventures (James Broderick)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
87 Cambridge Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
Ra Pharmaceuticals is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma's peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Doug Treco
Chief Financial Officer
David Lubner
Chief Medical Officer
Ramin Farzaneh-Far
Chief Scientific Officer
Simon Read
VP - R & D
Alonso Ricardo
Browse more venture capital transactions:
Prev: 2/25/2010: eHealth Global Technologies venture capital transaction
Next: 2/25/2010: Enerkem venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs